A two-photon fluorescent probe for sensitive detection and imaging of γ-glutamyl transpeptidase

Ruijin Huo1, Xiuli Zheng2, Weimin Liu1

  • 1Key Laboratory of Photochemical Conversion and Optoelectronic Materials and City U-CAS Joint Laboratory of Functional Materials and Devices, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, P. R. China. wmliu@mail.ipc.ac.cn wangpf@mail.ipc.ac.cn and School of Future Technology, University of Chinese Academy of Sciences, Beijing 100049, P. R. China.

Chemical Communications (Cambridge, England)
|August 19, 2020
PubMed

Insights

A novel fluorescent probe, 4F-2CN-GSH, was created to detect gamma-glutamyl transpeptidase (GGT). This probe can identify ovarian cancer cells using advanced fluorescence imaging techniques.

Area of Science:

  • Biochemistry
  • Chemical Biology
  • Medical Imaging

Background:

  • Gamma-glutamyl transpeptidase (GGT) is an enzyme linked to various physiological processes and diseases, including cancer.
  • Developing selective and sensitive probes for GGT is crucial for early disease detection and diagnosis.
  • Fluorescence imaging offers a powerful tool for visualizing biological processes at the cellular level.

Purpose of the Study:

  • To develop a novel GGT-activated two-photon fluorescent probe for selective GGT detection.
  • To evaluate the probe's performance in terms of sensitivity and specificity.
  • To demonstrate the probe's utility in distinguishing ovarian cancer cells from normal cells using fluorescence imaging.

Main Methods:

  • A cascade reaction was employed to synthesize the GGT-activated two-photon fluorescent probe (4F-2CN-GSH).
  • The probe's fluorescence properties and selectivity for GGT were characterized.
  • One-photon and two-photon fluorescence imaging were utilized to assess the probe's ability to detect GGT in ovarian cancer cells and normal cells.

Main Results:

  • The developed probe (4F-2CN-GSH) demonstrated selective activation by GGT.
  • The probe exhibited a low detection limit for GGT.
  • Successful distinction between ovarian cancer cells and normal cells was achieved using both one-photon and two-photon fluorescence imaging.

Conclusions:

  • A GGT-activated two-photon fluorescent probe (4F-2CN-GSH) was successfully developed.
  • The probe offers a sensitive and selective method for GGT detection.
  • This probe holds potential for fluorescence imaging-based diagnosis of ovarian cancer.